Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness
Description:
This book provides a comprehensive review of melancholia as a severe disorder of mood, associated with suicide, psychosis, and catatonia. The syndrome is defined with a clear diagnosis, prognosis, and range of management strategies, differentiated from other similar psychiatric, neurological, and general medical conditions. It challenges accepted doctrines in the classification and biology of the mood disorders and defines melancholia as a treatable mental illness. Described for millennia in medical texts and used as a term in literature and poetry, melancholia was included within early versions of the major diagnostic classificatory systems, but lost favour in later editions. This book updates the arguments for the diagnosis, describes its characteristics in detail, and promotes treatment and prevention. The book offers great hope to those with a disorder too often mis-diagnosed and often fatal. It should be read by all those responsible for the management of patients with mood disorders.
Best prices to buy, sell, or rent ISBN 9780521841511
Frequently Asked Questions about Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness
The price for the book starts from $56.47 on Amazon and is available from 13 sellers at the moment.
If you’re interested in selling back the Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness book, the best buyback offer comes from and is $ for the book in good condition.
The Melancholia: The Diagnosis, Pathophysiology and Treatment of Depressive Illness book is in very low demand now as the rank for the book is 6,026,849 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.